Shigellosis News and Research

RSS
UMSOM researchers to test the safety, tolerability of prototype Shigella-ETEC vaccine

UMSOM researchers to test the safety, tolerability of prototype Shigella-ETEC vaccine

Early adherence step in intestinal transit of Shigella discovered

Early adherence step in intestinal transit of Shigella discovered

UMSOM receives landmark contract from NIAID for influenza research

UMSOM receives landmark contract from NIAID for influenza research

New study launched in Burkina Faso to test typhoid conjugate vaccine

New study launched in Burkina Faso to test typhoid conjugate vaccine

Unrecognized childhood infections far greater threat than previously realized

Unrecognized childhood infections far greater threat than previously realized

First African child vaccinated with new typhoid conjugate vaccine

First African child vaccinated with new typhoid conjugate vaccine

Genomic sequencing reveals new insights into major shigellosis outbreaks in California

Genomic sequencing reveals new insights into major shigellosis outbreaks in California

New research shows childhood diarrhea cases significantly higher than estimated

New research shows childhood diarrhea cases significantly higher than estimated

UM SOM selected as study site for human safety trial of new Zika vaccine

UM SOM selected as study site for human safety trial of new Zika vaccine

International travelers bring multidrug-resistant shigellosis to the US

International travelers bring multidrug-resistant shigellosis to the US

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

Study shows how anaplasma phagocytophilum subverts natural processes

Study shows how anaplasma phagocytophilum subverts natural processes

Scientists discover new genetic information linked with shigellosis

Scientists discover new genetic information linked with shigellosis

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Phase I study of Shigella dysenteriae bioconjugate vaccine meets primary, secondary endpoints

Phase I study of Shigella dysenteriae bioconjugate vaccine meets primary, secondary endpoints

Media examine floods' impact in Pakistan

Media examine floods' impact in Pakistan

Breast-feeding may help lower risk of death from Shigella infection in developing countries: Study

Breast-feeding may help lower risk of death from Shigella infection in developing countries: Study

Haitian President says up to 300,000 people could have died in quake

Haitian President says up to 300,000 people could have died in quake

U.S. army Phase I STTR contract for Intralytix

U.S. army Phase I STTR contract for Intralytix